急性B型主动脉夹层早期胸主动脉腔内修复与并发症增加相关:Gore全球血管腔内主动脉治疗注册研究结果
基于Gore全球血管腔内主动脉治疗注册研究(GREAT)中172例因B型主动脉夹层接受胸主动脉腔内修复(TEVAR)的患者,比较症状发作3天内与延迟TEVAR的结局。校正复杂表现后,3天内TEVAR与短期及中期主动脉并发症增加独立相关。作者建议无并发症急性B型主动脉夹层患者如条件允许应将TEVAR延迟至少3天以最大程度降低风险。
要点
- GREAT注册中172例B型主动脉夹层患者接受TEVAR,其中102例(59%)为复杂表现。
- 校正复杂表现后,症状发作3天内TEVAR与短期主动脉并发症增加独立相关(OR 2.4,P<0.039)。
- 3天内TEVAR还与中期主动脉并发症增加独立相关(HR 2.31,P<0.024)。
核心结论
- 数据提示急性B型主动脉夹层至少3天后行TEVAR与较低的发病率和死亡率相关。
- 作者建议无并发症急性B型主动脉夹层患者如条件允许应将TEVAR延迟至少3天以最大程度降低风险。
研究设计与样本
- 回顾性查询GREAT注册研究2011至2016年因B型主动脉夹层接受TEVAR的患者。
- 共纳入172例患者,40例(23%)为女性,平均年龄61±12岁。
- 急性期定义为症状发作14天内住院,时间从首次症状计算至TEVAR植入。
- 复杂表现由治疗中心指定,治疗策略由医生决定。
- 所有患者接受Gore TAG或CTAG装置行TEVAR。
主要发现
- 172例中102例(59%)为复杂表现。
- 校正复杂表现后,症状发作3天内TEVAR与短期主动脉并发症增加独立相关(OR 2.4,P<0.039)。
- 校正复杂表现后,症状发作3天内TEVAR与中期主动脉并发症增加独立相关(HR 2.31,P<0.024)。
- 与延迟修复相比,3天内TEVAR还与主动脉再干预、分支血管并发症、肾脏并发症及6个月时主动脉并发症/死亡的发生率增加相关。
临床怎么用
- 作者建议无并发症急性B型主动脉夹层患者如条件允许应将TEVAR延迟至少3天以最大程度降低风险。
局限性
- 复杂表现的 designation 由治疗中心指定,与最新Society for Vascular Surgery/Society of Thoracic Surgeons报告标准不同,后者仅指灌注不良和破裂。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Several recent small trials have suggested that there is a potential benefit of early thoracic endovascular aortic repair (TEVAR) for acute type B aortic dissection (TBAD), even for uncomplicated patients. We studied patients enrolled in the Gore Global Registry for Endovascular Aortic Treatment (GREAT) to compare outcomes of TEVAR in the early-acute phase with and without complicated presentation. METHODS: The GREAT registry was queried for patients treated with TEVAR for TBAD. Acute phase of TBAD was defined as hospitalization within 14 days of symptom onset. Time to treatment was computed as time from first symptoms to time of TEVAR implantation regardless of the preoperative duration of hospitalization. Complicated presentation of acute TBAD was designated by the treating clinical sites, and treatment strategy was determined at the physician's discretion, as was common practice at the time of registry conception in 2010; therefore, the designation of "complicated" presentation in this study differs from the most recent Society for Vascular Surgery/Society of Thoracic Surgeons reporting standards, which refers exclusively to malperfusion and rupture. All patients received TEVAR with Gore TAG or CTAG devices (W.L. Gore & Associates, Flagstaff, Arizona). The primary exposure variable was time from symptom onset to TEVAR, stratified by complicated versus uncomplicated presentation. The primary outcome was postoperative aortic complications, defined as endoleak, extended or new dissection (including retrograde type A dissection), rupture, enlargement or aneurysmal degeneration, requirement for reinterventions, conversion to open repair, and graft infection. Univariate data were analyzed by contingency table and unpaired t-test or Wilcoxon rank sum, and adjusted analyses were conducted using stratified and multiple logistic and Cox regression techniques. Data were analyzed by an independent academic research team. RESULTS: Of the 5,014 patients enrolled in the GREAT registry between 2011 and 2016, there were 172 patients who received TEVAR for TBAD; 40 of 172 (23%) were female and the mean age was 61 ± 12 years. There were 102 (59%) with complicated presentations. After adjustment for complicated presentation, TEVAR performed within 3 days of symptom onset was independently associated with increased rate of short-term (odds ratio, 2.4, P < 0.039), and intermediate-term (hazard ratio 2.31, P < 0.024) aortic complications. TEVAR performed within 3 days was also associated with increased rates of aortic reinterventions, branch vessel complications, renal complications, and aortic complication/death at 6 months when compared with delayed repair. CONCLUSION: These data suggest that TEVAR performed at least 3 days after acute TBAD is associated with less morbidity and mortality. When possible, TEVAR should be delayed by at least 3 days for patients with uncomplicated acute TBAD to offer maximum risk reduction.
引用
- Potter HA, Miller CC, Sandhu HK, et al. Early Thoracic Endovascular Aortic Repair for Acute Type B Dissection Is Associated with Increased Complications: Results from the Gore Global Registry for Endovascular Aortic Treatment Registry. Ann Vasc Surg. 2025. PMID: 40233894. doi:10.1016/j.avsg.2025.03.020
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。